Literature DB >> 23615859

The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.

Lin Zhang1, Limei Han, Jing Qin, Weiyue Lu, Jianxin Wang.   

Abstract

PURPOSE: To evaluate the effect of borneol on the brain targeting efficiency of aprotinin-conjugated poly (ethyleneglycol)-poly (L-lactic-co-glycolic acid) nanoparticles (Apr-NP) and the activity of huperzine A (Hup A) loaded nanoparticles to AD rats .
METHOD: Apr-NP was prepared by emulsion and solvent evaporation method. The uptake of Apr-NP alone or combined with borneol by brain capillary endothelial cells (BCECs) was evaluated by incorporating coumarin-6 as a tracer. In vivo imaging and the distribution of Hup A in the brain were measured to investigate the brain delivery of Apr-NP in rats, with or without the oral administration of borneol. Morris water maze was used to evaluate the memory improvement effect of Hup A loaded nanoparticles (Apr-NP-Hup).
RESULTS: Co-incubation with borneol could increase the uptake of nanoparticles by BCECs. Nanoparticles delivered into the rat brain were enhanced significantly by the co-administration of borneol. The pharmacological effects of Hup A loaded nanoparticles on improving the memory impairment of AD rats were greatly improved when combined with borneol.
CONCLUSIONS: Borneol is a promising enhancer for brain-targeting delivery systems. When co-administered with aprotinin-modified nanoparticles, borneol could improve the brain targeting efficiency of nanoparticles significantly.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615859     DOI: 10.1007/s11095-013-1055-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

Review 1.  Fragrance material review on borneol.

Authors:  S P Bhatia; C S Letizia; A M Api
Journal:  Food Chem Toxicol       Date:  2008-07-01       Impact factor: 6.023

Review 2.  Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Authors:  Rui Wang; Han Yan; Xi-can Tang
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

3.  Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease.

Authors:  Armen A Galoyan; John S Sarkissian; Vergineh A Chavushyan; Irina B Meliksetyan; Zaruhi E Avagyan; Mikhail V Poghosyan; Hasmik G Vahradyan; Hovhannes H Mkrtchian; Davit O Abrahamyan
Journal:  Alzheimers Dement       Date:  2008-09       Impact factor: 21.566

4.  Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration.

Authors:  Ziyi Wen; Zhiqiang Yan; Kaili Hu; Zhiqing Pang; Xufei Cheng; LiangRan Guo; Qizhi Zhang; Xinguo Jiang; Liang Fang; Ren Lai
Journal:  J Control Release       Date:  2011-02-26       Impact factor: 9.776

5.  Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration.

Authors:  Yang Lu; Shou-ying Du; Xiao-lan Chen; Qing Wu; Xiao Song; Bing Xu; Yong-song Zhai
Journal:  J Zhejiang Univ Sci B       Date:  2011-02       Impact factor: 3.066

6.  Effects of olanzapine, sertindole and clozapine on learning and memory in the Morris water maze test in naive and MK-801-treated mice.

Authors:  Oguz Mutlu; Güner Ulak; Ipek Komsuoglu Celikyurt; Füruzan Yildiz Akar; Faruk Erden
Journal:  Pharmacol Biochem Behav       Date:  2011-02-17       Impact factor: 3.533

Review 7.  Active targeting of brain tumors using nanocarriers.

Authors:  Arnaud Béduneau; Patrick Saulnier; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2007-08-22       Impact factor: 12.479

8.  Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Authors:  Changyou Zhan; Bing Gu; Cao Xie; Jin Li; Yu Liu; Weiyue Lu
Journal:  J Control Release       Date:  2010-01-07       Impact factor: 9.776

9.  Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.

Authors:  Jungang Ren; Meijuan Zou; Ping Gao; Yue Wang; Gang Cheng
Journal:  Eur J Pharm Biopharm       Date:  2012-11-29       Impact factor: 5.571

10.  Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

Authors:  Michel Demeule; Jean-Christophe Currie; Yanick Bertrand; Christian Ché; Tran Nguyen; Anthony Régina; Reinhard Gabathuler; Jean-Paul Castaigne; Richard Béliveau
Journal:  J Neurochem       Date:  2008-05-19       Impact factor: 5.372

View more
  15 in total

Review 1.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.

Authors:  Qun-Lin Zhang; Bingmei M Fu; Zhang-Jin Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 3.  Progress and perspectives on targeting nanoparticles for brain drug delivery.

Authors:  Huile Gao
Journal:  Acta Pharm Sin B       Date:  2016-06-14       Impact factor: 11.413

Review 4.  Towards Improvements for Penetrating the Blood-Brain Barrier-Recent Progress from a Material and Pharmaceutical Perspective.

Authors:  Quanguo He; Jun Liu; Jing Liang; Xiaopeng Liu; Wen Li; Zhi Liu; Ziyu Ding; Du Tuo
Journal:  Cells       Date:  2018-03-23       Impact factor: 6.600

5.  The Role and Mechanism of Borneol to Open the Blood-Brain Barrier.

Authors:  Tao Wu; Aiqin Zhang; Hongyang Lu; Qiaoyuan Cheng
Journal:  Integr Cancer Ther       Date:  2018-04-13       Impact factor: 3.279

6.  Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer.

Authors:  Zheng Cai; Xiaolu Lei; Zhufen Lin; Jie Zhao; Feizhen Wu; Zhaoxiang Yang; Junxue Pu; Zhongqiu Liu
Journal:  Acta Pharm Sin B       Date:  2014-01-24       Impact factor: 11.413

7.  Treatment Efficacy of NGF Nanoparticles Combining Neural Stem Cell Transplantation on Alzheimer's Disease Model Rats.

Authors:  Yan Chen; Cuihuan Pan; Aiguo Xuan; Liping Xu; Guoqing Bao; Feiei Liu; Jie Fang; Dahong Long
Journal:  Med Sci Monit       Date:  2015-11-21

8.  Exploiting macrophages as targeted carrier to guide nanoparticles into glioma.

Authors:  Liang Pang; Jing Qin; Limei Han; Wenjie Zhao; Jianming Liang; Zhongyi Xie; Pei Yang; Jianxin Wang
Journal:  Oncotarget       Date:  2016-06-14

9.  Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.

Authors:  Qingqing Meng; Aiping Wang; Hongchen Hua; Ying Jiang; Yiyun Wang; Hongjie Mu; Zimei Wu; Kaoxiang Sun
Journal:  Int J Nanomedicine       Date:  2018-02-01

10.  Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.

Authors:  Xiuju Yan; Lixiao Xu; Chenchen Bi; Dongyu Duan; Liuxiang Chu; Xin Yu; Zimei Wu; Aiping Wang; Kaoxiang Sun
Journal:  Int J Nanomedicine       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.